Date: Wednesday 13 November 2013
Venue: Queen Elizabeth II Conference Centre, London
Welcome Addresses
Dr Ranjababu Kulasegaram, Chair, BHIVA Hepatitis Society
Professor Graham Foster, Chair, British Association for the Study of the Liver (BASL)
Dr Ashley Brown, Chair, British Viral Hepatitis Group (BVHG)
Plenary Session 1
When to treat HIV/hepatitis co-infection outside drug trials: treat now or wait?
Professor Graham Foster, Queen Mary, University of London
Advances in hepatitis B
Professor Karine Lacombe, Hospital Saint-Antoine, Paris, France
Plenary Session 2
Insights into the immunopathogenesis of liver disease in HCV/HIV co-infected patients
Professor Paul Klenerman, University of Oxford
Treating NASH in HIV co-infection
Professor Mark Thursz, Imperial College Healthcare NHS Trust, London
What's in the pipeline? (part 1)
Dr Mariem Charafeddine, AbbVie Ltd
Mrs Tokunbo Soyemi, Boehringer Ingelheim Ltd
Mr Jonty Manuja, Janssen
Debate - The motion: Should HIV physicians treat patients infected with hepatitis?
For the motion:
Dr Mark Nelson, Chelsea and Westminster Hospital, London
Against the motion:
Dr Kosh Agarwal, King's College Hospital, London
Plenary Session 3
Hepatocellular carcinomas (HCCs)
Professor Norbert Bräu, James J Peters VA Medical Center, New York, USA
Update on liver transplantation in HIV/hepatitis co-infected patients
Dr James O'Beirne, Royal Free Hospital, London
What's in the pipeline? (part 2)
Dr David Butcher, Bristol-Myers Squibb Ltd
Dr Macky Natha, Gilead Sciences Ltd
Dr Valerie Carr, Janssen Therapeutics EMEA
Dr Nadine Chamay, MSD Ltd
Plenary Session 4
BHIVA guidelines for the management of co-infection with HIV-1 and hepatitis viruses update
Dr Ed Wilkins, North Manchester General Hospital
Difficult HIV/hepatitis co-infection case presentation session
A fly in the face
Dr Olubanke Davies, St Thomas' Hospital, London
Hepatitis B/HIV co-infection in renal disease
Dr Anna Goodman, Royal Free Hospital, London
Expanded Access: a marginal decision
Dr Agata Plonczak, Chelsea and Westminster Hospital, London
Close
Dr Ranjababu Kulasegaram, Chair, BHIVA Hepatitis Society
Dr Ashley Brown, Chair, British Viral Hepatitis Group (BVHG) and on behalf of the British Association for the Study of the Liver (BASL)